Global Gastroesophageal Reflux Disease Treatment Device Market Size By Type (Invasive Surgery, Non Invasive Surgery), By Application (Government, Hospitals), By Region, And Segment Forecasts, 2023 to...

The Global Gastroesophageal Reflux Disease (GERD) Treatment Device Market was valued at USD 850 million in 2023 and is projected to reach USD 1.52 billion by 2031, growing at a CAGR of 7.4% during the forecast period from 2023 to 2031. GERD is a chronic digestive condition affecting millions globally, characterized by acid reflux that can significantly impair quality of life. The increasing prevalence of GERD, rising preference for minimally invasive treatment alternatives, and technological innovations in anti-reflux devices are key drivers propelling market growth. Additionally, growing awareness and diagnosis rates, especially in emerging economies, are expanding the market base for GERD treatment devices.

Drivers

1. Rising Prevalence of GERD:

The global burden of GERD is increasing, driven by sedentary lifestyles, unhealthy dietary habits, and obesity. According to clinical estimates, over 20% of the global population experiences GERD symptoms weekly, creating a consistent demand for effective treatment solutions.

2. Demand for Minimally Invasive Treatments:

Patients and healthcare providers are favoring non-pharmacologic, device-based interventions such as magnetic sphincter augmentation and radiofrequency ablation. These devices offer long-term relief with fewer side effects compared to proton pump inhibitors (PPIs), contributing to market expansion.

3. Advancements in Device Technology:

Innovation in GERD treatment devices, including the development of compact, implantable systems and enhanced endoscopic solutions, is enhancing treatment efficacy and patient comfort. Integration with real-time monitoring technologies is further supporting clinical adoption.

Restraints

1. High Cost of Advanced Devices:

The adoption of GERD treatment devices can be limited by high procedural and device costs, especially in low-income regions. Insurance coverage inconsistencies further restrict access for a broad patient base.

2. Regulatory Challenges:

Medical devices undergo rigorous clinical testing and regulatory approval, which can delay product launches and inflate development costs. Stringent compliance requirements can also deter smaller manufacturers from entering the market.

Opportunity

1. Expansion in Emerging Markets:

Rapidly growing healthcare infrastructure, increasing GERD awareness, and higher disposable incomes in Asia-Pacific and Latin America are presenting significant growth opportunities for device manufacturers.

2. Technological Integration with AI and Remote Monitoring:

Integration of AI-based analytics and remote patient monitoring with GERD devices is an emerging trend, offering enhanced diagnostic and post-treatment management capabilities. This innovation holds potential to differentiate offerings and capture new customer segments.

Market by System Type Insights

Among device types, magnetic sphincter augmentation systems dominated the market in 2023, accounting for the largest revenue share. These systems, such as the LINX device, have gained widespread acceptance due to their minimally invasive nature and long-term efficacy. However, endoscopic therapy devices are expected to exhibit the fastest growth, driven by rising demand for outpatient procedures and continuous product advancements.

Market by End-use Insights

Hospitals represented the largest end-use segment in 2023, owing to the higher availability of advanced surgical equipment and skilled professionals. Meanwhile, ambulatory surgical centers (ASCs) are expected to grow at a higher CAGR during the forecast period due to increased patient preference for same-day procedures and lower treatment costs in these settings.

Market by Regional Insights

North America held the largest share of the GERD treatment device market in 2023, supported by a high prevalence of GERD, favorable reimbursement structures, and well-established healthcare infrastructure. The Asia-Pacific region is projected to grow at the fastest pace through 2031, fueled by increased healthcare investment, growing GERD incidence, and rising awareness initiatives in countries like China, India, and Japan.

Competitive Scenario

Key players in the Global GERD Treatment Device Market include Medtronic plc, EndoGastric Solutions, Johnson & Johnson (Ethicon), Torax Medical (acquired by Ethicon), ReShape Lifesciences Inc., Medigus Ltd., and Mederi Therapeutics Inc. These companies are prioritizing research and development, strategic acquisitions, and regional expansion to consolidate their market position.

In 2023, EndoGastric Solutions expanded its distribution network for the EsophyX Z+ system across European markets.

In 2024, Medtronic launched its AI-integrated reflux monitoring system for better post-treatment diagnostics.

In 2025, Johnson & Johnson introduced a next-generation laparoscopic anti-reflux device aimed at outpatient surgical centers.

Scope of Work – Global Gastroesophageal Reflux Disease Treatment Device Market

Report Metric Details

Market Size (2023) USD 850 million

Projected Market Size (2031) USD 1.52 billion

CAGR (2023–2031) 7.4%

Market Segments By System Type, End-Use, Region

Growth Drivers Rising GERD prevalence, Minimally Invasive Treatment Demand, Device Innovation

Opportunities Emerging Markets, AI-Integrated Monitoring

Key Market Developments

2023: EndoGastric Solutions expanded the reach of its EsophyX Z+ device in Southeast Asia.

2024: Medtronic introduced an AI-powered post-GERD treatment analytics tool integrated with wearable devices.

2025: ReShape Lifesciences received FDA clearance for a novel endoscopic GERD treatment device targeting outpatient use.

FAQs

1) What is the current market size of the Global Gastroesophageal Reflux Disease Treatment Device Market?

The market was valued at USD 850 million in 2023.

2) What is the major growth driver of the Global Gastroesophageal Reflux Disease Treatment Device Market?

The rising demand for minimally invasive GERD treatments and the growing prevalence of the disease are key drivers.

3) Which is the largest region during the forecast period in the Global Gastroesophageal Reflux Disease Treatment Device Market?

North America is the leading region by market share.

4) Which segment